[1]
2023. Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis. Clinics. 78, (Jan. 2023), 100152. DOI:https://doi.org/10.1016/j.clinsp.2022.100152.